88 related articles for article (PubMed ID: 5030949)
1. Cell-mediated immunity directed against a syngeneic plasma cell tumor in the mouse. Detection by macrophage-migration inhibition test.
Poupon MF; Lespinats G
J Natl Cancer Inst; 1972 May; 48(5):1297-301. PubMed ID: 5030949
[No Abstract] [Full Text] [Related]
2. Cellular immunity to solubilized tumor antigens of a methylcholanthrene-induced sarcoma with a migration inhibition assay.
Padarathsingh ML; Dean JH; McCoy JL; Lewis DD; Northing JW; Natori T; Law LW
J Immunol; 1978 Jun; 120(6):1981-5. PubMed ID: 659888
[TBL] [Abstract][Full Text] [Related]
3. [Specific cell-mediated immunity in batrachians. I. Quantitative method of determination with the macrophage-migration-inhibition-test for peritoneal exudate cells and spleen fragments].
Ambrosius H; Drössler K
Acta Biol Med Ger; 1972; 29(3):441-5. PubMed ID: 4630831
[No Abstract] [Full Text] [Related]
4. Blocking effect of the migration-inhibition reaction by sera from immunized syngeneic mice and by sera from plasmacytoma-bearing BALB-c mice. Detection of free, circulating tumor antigen.
Poupon MF; Lespinats G; Kolb JP
J Natl Cancer Inst; 1974 Apr; 52(4):1127-34. PubMed ID: 4826584
[No Abstract] [Full Text] [Related]
5. Indirect migration inhibition test in xenogeneic systems. 3. Cellular immunity to kidney grafts.
Skopińska E; Wasik M; Wojtulewicz-Kurkus J
Arch Immunol Ther Exp (Warsz); 1971; 19(3):377-80. PubMed ID: 4938013
[No Abstract] [Full Text] [Related]
6. Tumor-specific resistance in mice detected by inhibition of macrophage migration.
Vaage J; Jones RD; Brown BW
Cancer Res; 1972 Apr; 32(4):680-7. PubMed ID: 4552377
[No Abstract] [Full Text] [Related]
7. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved.
Cihak J; Ziegler HW; Kölsch E
Immunology; 1981 May; 43(1):133-43. PubMed ID: 6265346
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
Toffaletti DL; Darrow TL; Scott DW
J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910
[TBL] [Abstract][Full Text] [Related]
9. Isolation of a specific plasmacytoma tumor antigen, reactive both in humoral and cell mediated immunity.
Kolb JP; Lespinats G; Poupon MF
Ann Immunol (Paris); 1974; 125 C(5):835-45. PubMed ID: 4142374
[No Abstract] [Full Text] [Related]
10. The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes.
Fujiwara H; Hamaoka T; Shearer GM; Yamamoto H; Terry WD
J Immunol; 1980 Feb; 124(2):863-9. PubMed ID: 6965392
[No Abstract] [Full Text] [Related]
11. [Cellular immunity in mouse plasmocytomas].
Lespinats G; Poupon MF
Ann Inst Pasteur (Paris); 1972 Apr; 122(4):755-65. PubMed ID: 5050876
[No Abstract] [Full Text] [Related]
12. [Cellular immunity and serum factors in plasmocytomas in mice].
Lespinats G; Poupon MF; Kolb JP
Bull Cancer; 1972; 59(4):353-62. PubMed ID: 4668253
[No Abstract] [Full Text] [Related]
13. Cell-mediated immunity against particulate and solubilized tumor-associated antigens of murine plasmacytomas detected by macrophage migration inhibition assays.
Padarathsingh ML; Dean JH; McCoy JL; Lewis DD; Northing JW; Natori T; Law LW
Int J Cancer; 1977 Oct; 20(4):624-31. PubMed ID: 914399
[TBL] [Abstract][Full Text] [Related]
14. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
[TBL] [Abstract][Full Text] [Related]
15. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression.
Ting CC; Rodrigues D
J Natl Cancer Inst; 1982 Oct; 69(4):867-72. PubMed ID: 6214653
[TBL] [Abstract][Full Text] [Related]
16. Effect of immunosuppressive drugs on an in vito correlate of cell-mediated immunity. The migration inhibition test.
Pekárek J; Svejcar J; Nouza K; Johanovsky J
Immunology; 1976 Nov; 31(5):773-9. PubMed ID: 791852
[TBL] [Abstract][Full Text] [Related]
17. Effect of bilirubin on an in vitro correlate of cell-mediated immunity--the migration inhibition test.
Svejcar J; Miler I; Pekárek J
J Clin Lab Immunol; 1984 Mar; 13(3):145-9. PubMed ID: 6371239
[TBL] [Abstract][Full Text] [Related]
18. [Macrophage migration method and results obtained by using it for the demonstration of cell-bound immune reactions against soluble and specific antigens, especially tumor-cell antigens].
Arndt A; Pasternak G
Arch Geschwulstforsch; 1972; 40(2):103-10. PubMed ID: 4563047
[No Abstract] [Full Text] [Related]
19. The development of cellular immunity to tumor cells.
Cerilli J; Smith MC
Surg Gynecol Obstet; 1972 May; 134(5):739-45. PubMed ID: 5064081
[No Abstract] [Full Text] [Related]
20. T-cell-mediated antitumor immune response induced by oncofetal antigens.
Gautam S; Deodhar SD
J Natl Cancer Inst; 1981 Oct; 67(4):939-45. PubMed ID: 6974275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
